I-Cabazitaxel 99%CAS 183133-96-2 ye-Cabazitaxel Resistant Prostate Cancer

Incazelo emfushane:

I-Cabazitaxel iyi-API ye-taxane anti-tumor.Ukuhlolwa kwemitholampilo kubonise ukuthi kunganciphisa nezimila, kubambezele ukukhula noma ukusabalala kwamathumba, kudambise izimpawu zomdlavuza wendlala yesinye futhi kuthuthukise izinga lempilo yeziguli.I-Cabazitaxel ihlanganiswe ne-prednisone yokwelapha umdlavuza wendlala yesinye we-hormone-refractory metastatic metastatic ngaphambilini owawulashwe ngohlelo oluqukethe i-docetaxel.I-Hand Bio ihlinzeka nge-cabazitaxel 99% CAS 183133-96-2 yomdlavuza wendlala yesinye.Ukuze uthole imininingwane eyengeziwe, sicela ukhululeke ukuxhumana ku-inthanethi.


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

Ulwazi Lomkhiqizo

Igama:I-Cabazitaxel

Inombolo ye-CAS:183133-96-2

Ifomula yekhemikhali:I-C45H57NO14

Imininingwane:99%

Umbala:impushana emhlophe noma emhlophe

Umthombo:Ihlanganiswe kancane ne-10-DAB

Uhlobo:Ama-API

Umsebenzi

Ukuhlolwa komtholampilo kubonise ukuthi i-cabazitaxel ingashwabana izimila, ibambezele ukukhula noma ukusabalala kwamathumba, futhi ikhulule izimpawu zomdlavuza wendlala yesinye.

Izindawo zokufaka izicelo

Imboni yezemithi

Amandla eSandla

U-Hande uneqembu le-R&D iminyaka eminingi.Ithimba lifake izicelo zokusungulwa kwenani lobunikazi, futhi inqubo ayinamthungo ukusuka elabhorethri ukuya ekukhiqizeni ngobuningi bokuthengisa.Isisekelo sokukhiqiza se-GMP esizakhele sona sesidlulile ekubuyekezweni kokulawula kwe-US FDA, EU EDQM, China GMP, Japan PMDA, Australia TGA, South Korea, India, China Taiwan, Turkey, Russia, SGS, Dun & Bradstreet neminye imithetho.Ngesikhathi esifanayo, inkampani ifakwe ithimba locwaningo nentuthuko, futhi ithole ngokulandelanayo inani lamalungelo obunikazi.Igumbi lokuhlola le-QC, qaphela kakhulu ukuhlolwa kwento yomkhiqizo.

Imboni yezandla

Iba umphakeli ongcono kakhulu wezinto ezingavuthiwe namabhizinisi ngobuqotho!

Siyakwamukela ukuthi uxhumane nami ngokuthumela i-imeyili kumarketing@handebio.com


  • Okwedlule:
  • Olandelayo: